Mergers and Acquisitions

(Artisanova/iStock via Getty Images Plus)

Advarra acquires Longboat

By Jenni Spinner

The clinical site services provider continues its series of strategic company purchases by bringing the Irish trial technologies firm under its umbrella.

(RG-vc/iStock via Getty Images Plus)

Advarra purchases IntegReview IRB

By Jenni Spinner

The institutional review board services provider has acquired the AAHRPP-accredited central IRB, which specializes in early-phase research.

(metamorworks/iStock via Getty Images Plus)

People on the Move: November 2020

By Jenni Spinner

The most recent news on pharmaceutical industry hires, promotions, acquisitions and other events includes Lonza, Medidata, Vetter, and Almac Group.

(Artsanova/iStock via Getty Images Plus)

Syneos Health to acquire Synteract

By Jenni Spinner

With the purchase, Syneos Health seeks to strengthen connections with the rapidly growing pre-revenue biopharmaceutical market, and expand global reach.

 (narith_2527/iStock via Getty Images Plus)

People on the Move: October 2020

By Jenni Spinner

The latest news on pharmaceutical industry hires, promotions, acquisitions and other events includes Medable, Eversana, Parexel, Astellas and more.

(Anastasia Usenko/iStock via Getty Images Plus)

Deloitte survey reveals pharma CEO thoughts

By Jenni Spinner

The latest iteration of the company’s Pharma CEO Survey offers information and insight as to how key industry figures are planning for the future.

(Kenishirotie/iStock via Getty Images Plus)

People on the Move: July 2020

By Jenni Spinner

Our latest spotlight on new hires, promotions and awards involves Lonza, ChargePoint Technology, Ashfield, Current Health and other industry firms.

(Image: Getty/metamorworks)

People on the Move: May 2020

By Jenni Spinner

This month’s new hires and promotions include executive appointments at Advarra, Eversana, Signant Health, Endpoint Clinical and other companies.

(Image: Getty/metamorworks)

Advarra purchases IRBco

By Jenni Spinner

The institutional review board and research technology solutions provider has acquired IRBco to expand its reach and presence in North America.

(Image: Getty/marchmeena29)

Amneal invests $340m in generics distributor

By Vassia Barba

Amneal announces acquisition of 65.1% majority interest of generics distributing company, AvKARE, boosting its presence in the generics and federal healthcare market.

(Image: Getty/Radachynskyi)

Recro spins out Baudax to boost CDMO focus

By Vassia Barba

Recro Pharma announces the separation of its acute care business to launch Baudax Bio as a developer of products, including non-opioid analgesics, to concentrate on its CDMO business.

(Image: Getty/BobHemphill)

Takeda sheds products in emerging markets in $200m deal

By Ben Hargreaves

Takeda has sold selected prescription and OTC products to Acino covering its Near East, Middle East and Africa portfolio, as it looks to trim down its portfolio following the acquisition of Shire.

(Image: Getty/Robert Daly)

UCB set to buy Ra Pharma for $2.1bn

By Ben Hargreaves

With both boards of directors in agreement, UCB is on track to add the clinical stage biopharma company and its lead drug candidate, zilucoplan, to its portfolio.

Follow us

Products

View more

Webinars